(Q39117681)

9 September 2017

title

Citric acid-γ-cyclodextrin crosslinked oligomers as carriers for doxorubicin delivery (English)

1 reference

9 September 2017

1 reference

Antonio Vargas-Berenguel

Antonio Vargas-Berenguel

9

0 references

Francesco Manoli

Francesco Manoli

4

0 references

Ilse Manet

Ilse Manet

3

0 references

Ruxandra Gref

10

Ruxandra Gref

1 reference

9 September 2017

Resmi Anand

1

1 reference

9 September 2017

Milo Malanga

2

1 reference

9 September 2017

Kata Tuza

5

1 reference

9 September 2017

Ahmet Aykaç

6

1 reference

9 September 2017

C Ladavière

7

1 reference

9 September 2017

Eva Fenyvesi

8

1 reference

9 September 2017

Sandra Monti

11

1 reference

9 September 2017

publication date

1 October 2013

1 reference

Photochemical and Photobiological Sciences

9 September 2017

published in

1 reference

9 September 2017

volume

12

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

1841-1854

1 reference

DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Cyclodextrin-based pharmaceutics: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Methyl-beta-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Beta-cyclodextrin conjugates with glucose moieties designed as drug carriers: their syntheses, evaluations using concanavalin A and doxorubicin, and structural analyses by NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Design, synthesis and evaluation of D-galactose-beta-cyclodextrin conjugates as drug-carrying molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Supramolecular hydrogels as a universal scaffold for stepwise delivering Dox and Dox/cisplatin loaded block copolymer micelles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Beta-cyclodextrin-centered star-shaped amphiphilic polymers for doxorubicin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Glutathione‐Induced Intracellular Release of Guests from Mesoporous Silica Nanocontainers with Cyclodextrin Gatekeepers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Multifunctional pH-Disintegrable micellar nanoparticles of asymmetrically functionalized β-cyclodextrin-Based star copolymer covalently conjugated with doxorubicin and DOTA-Gd moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Supramolecular hydrogels from in situ host-guest inclusion between chemically modified cellulose nanocrystals and cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Spontaneous association of hydrophobized dextran and poly-beta-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Preparation and characterization of water soluble high molecular weight β-cyclodextrin-epichlorohydrin polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

New self-assembled nanogels based on host-guest interactions: characterization and drug loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

β-Cyclodextrin polymer nanoparticles as carriers for doxorubicin and artemisinin: a spectroscopic and photophysical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Bone implants modified with cyclodextrin: Study of drug release in bulk fluid and into agarose gel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Methyl-β-cyclodextrin modified vascular prosthesis: Influence of the modification level on the drug delivery properties in different media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Cyclodextrin polymers as efficient solubilizers of albendazole: complexation and physico-chemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Circular dichroism studies on anthracycline antitumor compounds. Relationship between the molecular structure and the spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Studies on self-aggregation of anthracycline drugs by restrained molecular dynamics approach using nuclear magnetic resonance spectroscopy supported by absorption, fluorescence, diffusion ordered spectroscopy and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Unravelling molecular mechanisms in the fluorescence spectra of doxorubicin in aqueous solution by femtosecond fluorescence spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Deciphering the fluorescence signature of daunomycin and doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

Association of anthracyclines and synthetic hexanucleotides. Structural factors influencing sequence specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

The anticancer drug-DNA complex: femtosecond primary dynamics for anthracycline antibiotics function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3PP50169H

21 January 2018

Identifiers

DOI

10.1039/C3PP50169H

1 reference

9 September 2017

1 reference